Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Beginning in 2023, five years after their European counterparts, ...
AbbVie’s megablockbuster TNF blocker Humira is about to face biosimilars next year. While new competitors will almost definitely drag down the behemoth drug’s sales, the question is, what pricing ...
North Chicago-based drugmaker AbbVie must pay back Medicare for raising the price of its blockbuster drug Humira too quickly, the federal government said Wednesday. The penalty follows years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback